An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies

Clinical trial NCT07101705 · RECRUITING

Trial details

NCT number

NCT07101705

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Status

RECRUITING

Phase

Early Phase 1

Study type

INTERVENTIONAL

Start date

2025-09-08

Primary completion

2028-08-01

Enrollment

40

View on ClinicalTrials.gov